- Kassira S , Korta DZ , Chapman LW , Dann F. Review of treatment for alopecia totalis and alopecia universalis. Int J Dermatol . 2017;56:801–810. doi:10.1111/ijd.13612.
- Lazzarini R , Capareli GC , Buense R , Lellis RF. Alopecia universalis during treatment with leflunomide and adalimumab—case report. An Bras Dermatol . 2014;89:320–322. doi:10.1590/abd1806-4841.20142944.
- Strazzulla LC , Wang EHC , Avila L , et al. Alopecia areata: disease characteristics, clinical evaluation, and new perspectives on pathogenesis. J Am Acad Dermatol . 2018;78:1–12. doi:10.1016/j.jaad.2017.04.1141.
- Garcia Bartels N , Lee H-H , Worm M , Burmester G-R , Sterry W , Blume-Peytavi U. Development of alopecia areata universalis in a patient receiving adalimumab. Arch Dermatol . 2006;142:1654–1655. doi:10.1001/archderm.142.12.1654.
- Ostojic P , Pavlov-Dolijanovic S. Alopecia universalis in a patient with rheumatoid arthritis developed during treatment with adalimumab. Z Rheumatol . 2018;77:412–415. doi:10.1007/s00393-018-0464-z.
- Chaves Y , Duarte G , Ben-Said B , Tebib J , Berard F , Nicolas JF. Alopecia areata universalis during treatment of rheumatoid arthritis with anti-TNF-alpha antibody (adalimumab). Dermatology (Basel) . 2008;217:380. doi:10.1159/000162180.
- Ettefagh L , Nedorost S , Mirmirani P. Alopecia areata in a patient using infliximab: new insights into the role of tumor necrosis factor on human hair follicles. Arch Dermatol . 2004;140:1012. doi:10.1001/archderm.140.8.1012-a.
- Tauber M , Buche S , Reygagne P , et al ; Groupe d’études thérapeutiques des affections inflammatoires du tube digestif (GETAID) . Alopecia areata occurring during anti-TNF therapy: a national multicenter prospective study. J Am Acad Dermatol . 2014;70:1146–1149. doi:10.1016/j.jaad.2014.03.005.
- Alkhalifah A , Alsantali A , Wang E , McElwee KJ , Shapiro J. Alopecia areata update: part I. Clinical picture, histopathology, and pathogenesis. J Am Acad Dermatol . 2010;62:177–188; quiz 189–190. doi:10.1016/j.jaad.2009.10.032.
- Gandhi V , Baruah MC , Bhattacharaya SN. Nail changes in alopecia areata: incidence and pattern. Indian J Dermatol Venereol Leprol . 2003;69:114–115.
- Gorcey L , Gordon Spratt EA , Leger MC. Alopecia universalis successfully treated with adalimumab. JAMA Dermatol . 2014;150:1341–1344. doi:10.1001/jamadermatol.2014.1544.
- Dhayalan A , King BA. Tofacitinib citrate for the treatment of nail dystrophy associated with alopecia universalis. JAMA Dermatol . 2016;152:492–493. doi:10.1001/jamadermatol.2015.3772.
- Wambier CG , Craiglow BG , King BA. Combination tofacitinib and oral minoxidil treatment for severe alopecia areata. J Am Acad Dermatol . 2019. [Epub ahead of print]. doi:10.1016/j.jaad.2019.08.080.
Baylor University Medical Center Proceedings
The peer-reviewed journal of Baylor Scott & White Health
Volume 33, 2020 - Issue 4
Case Studies
Alopecia universalis and onychodystrophy during treatment with adalimumab
Ronnie Youssefa College of Medicine, Texas A&M Health Science Center, Dallas, TexasCorrespondence[email protected]
https://orcid.org/0000-0002-8460-5810
, BShttps://orcid.org/0000-0002-8460-5810, Saadeddine Saadb Department of Dermatology, Baylor Scott & White Medical Center–Temple, Temple, Texashttps://orcid.org/0000-0003-1852-1886
, MDhttps://orcid.org/0000-0003-1852-1886 & , MD